National Cancer Institute   Cancer Therapy Evaluation Program   Developing Cancer Therapies
CTEP HomeContactHelpSearch:

Reporting Guidelines

CTEP, NCI Guidelines: Adverse Event Reporting Requirements

Clinical Data Update System (CDUS)
Primary data reporting mechanism for all NCI-sponsored clinical trials.

CTCAE (formerly known as CTC) v2.0 and v3.0
Standard terminology used to name and to describe the severity (grade) of Adverse Events that occur in the treatment of cancer.

Adverse Event Expedited Reporting System (AdEERS)
System for all NCI collaborators providing electronic acquisition, exchange, submission, and analysis of Expedited Reports for serious and/or unexpected Adverse Events.

Gender and Minority Accrual Data
NIH Policy and Guidelines on the Inclusion of Women and Minorities Subjects in Clinical Research

NCI Secondary AML/MDS Form (PDF)
Form to be submitted to CTEP within 30 days of AML/MDS/ALL diagnosis following systemic anti-cancer therapy on NCI-sponsored trials.


  Home   |   Contact   |   Privacy Notice   |   Accessibility National Cancer Institute   National Institutes of Health   Department of Health and Human Services   USA.gov